Pardes Biosciences has hired Philippe Tinmouth to lead the execution of the company’s business development and strategic opportunities.
Tinmouth brings more than 25 years of experience. Most recently, he served as VP and head of business development at Vertex Pharmaceuticals. Prior to that, he worked at Bain & Co., advising pharma and smaller biotech companies on growth strategies.
A clinical-stage company, Pardes is developing a SARS-CoV-2 oral antiviral drug.